Docoh
Loading...

MDGS Medigus

Filed: 4 Dec 20, 10:45am

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of December 2020

 

Commission File Number 001-37381

 

MEDIGUS LTD.
(Translation of registrant’s name into English)

 

Omer Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒  Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __

 

 

 

 

 

 

 

EXPLANATORY NOTE

 

On December 4, 2020, Medigus Ltd. issued a press release titled: “Medigus Closes of $13 Million Underwritten Public Offering of ADSs.” A copy of this press release is furnished herewith as exhibit 99.1.

 

This report on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-238162 and No. 333-237774) and Form S-8 (File No. 333-206803, No. 333-221019 and No. 333-229429). 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 MEDIGUS LTD.
   
Date: December 4, 2020 By:/s/ Liron Carmel
  Liron Carmel
  Chief Executive Officer  

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit Description
   
99.1 Press release titled: “Medigus Closes of $13 Million Underwritten Public Offering of ADSs” dated December 4, 2020.